UNDERSTANDING IMMUNOSUPPRESSANT USE IN KIDNEY TRANSPLANTATION: MAJOR CHANGES IN DRUG REGIMEN, SHIFTS IN DOSING OVER TIME, AND KAPLAN-MEIER SURVIVAL ESTIMATES BY MAJOR ERA USING THE ANZDATA REGISTRY
JavaScript is disabled for your browser. Some features of this site may not work without it.
UNDERSTANDING IMMUNOSUPPRESSANT USE IN KIDNEY TRANSPLANTATION: MAJOR CHANGES IN DRUG REGIMEN, SHIFTS IN DOSING OVER TIME, AND KAPLAN-MEIER SURVIVAL ESTIMATES BY MAJOR ERA USING THE ANZDATA REGISTRY